SCHEMBL1936080

SCHEMBL1936080

CCOC(=O)Nc1ccc(CO)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.59
NPC1 O15118 3/20 0.59
HPGD P15428 2/20 0.59
CRHBP P24387 1/20 0.59
CRHR2 Q13324 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.55
ALDH1A1 P00352 3/20 0.54
TSHR P16473 2/20 0.54
LMNA P02545 2/20 0.54
HSD17B10 Q99714 2/20 0.54
KDM4E B2RXH2 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
RECQL P46063 1/20 0.54
CYP2C9 P11712 3/20 0.52
CYP2C19 P33261 3/20 0.52
CYP2D6 P10635 2/20 0.52
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 1/20 0.51
HTT P42858 1/20 0.51
MTNR1B P49286 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565510 0.89 RAB9A (0.71) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL940111 0.87 RAB9A (0.61) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL10205641 0.87 RAB9A (0.61) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL1903659 0.86 CYP4F2 (0.58) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL8112075 0.84 RAB9A (0.58) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL14349951 0.84 RAB9A (0.58) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL5561966 0.84 RAB9A (0.58) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL6404645 0.83 NPC1 (0.54) RAB9ANPC1HPGDCRHBPCRHR2
SCHEMBL29892760 0.83 RAB9A (0.67) RAB9ANPC1HPGDSMN1; SMN2ALDH1A1
SCHEMBL9146676 0.83 LMNA (0.68) RAB9ANPC1HPGDCRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103958506-B 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH 诺华股份有限公司 2017-02-22 CN disclosed
EP-2331518-A1 NEW BRADYKININ B1 ANTAGONISTS Evotec AG (DE) 2011-06-15 EP disclosed